Literature DB >> 23661827

Malignant tumours of the genital tract among Batswana women.

M N Tanko1, M A Kayembe, F Cainelli, S Vento.   

Abstract

BACKGROUND: To determine the frequency and pattern of malignant tumours of the female genital tract among Batswana women.
DESIGN: A four-year retrospective histological study of the pattern of female genital tract malignancy in Botswana.
SETTING: University of Botswana and the National Health Laboratory Gaborone, Botswana. The National Health Laboratory is the only public tertiary referral laboratory that provides diagnostic pathology services in the South-Eastern part of Botswana. It is located just adjacent to Princess Marina Hospital, the major tertiary referral hospital in the country.
METHODS: All histologically confirmed diagnoses of female genital tract malignancies from January 1(st) 2006 to December 31(st) 2009 were reviewed by two pathologists and diagnoses re-confirmed by taking fresh tissue sections from paraffin embedded archival tissue blocks.
RESULTS: The age of patients ranged from 13-96 years with a mean age of 54.5 ± 6.4 years. Cancer of the cervix constituted 80.6%, followed by uterine cancer (10.0%), carcinomas of the vulva (4.5%) and ovary (3.4%) in that order. Ovarian cancers predominated in the younger age group. There was a steady increase in the frequencies of cervical, uterine and ovarian cancers over the 4-year study period with a decline in uterine cancer in the 4(th) year.
CONCLUSION: Cervical cancer incidence is high among Batswana women and all female genital tract cancers occurred at a relatively early mean age. Therefore the importance of established and accessible screening programs and awareness campaigns need more emphasis than it is being given currently.

Entities:  

Keywords:  Batswana women; Malignant pattern; female genital tract

Mesh:

Year:  2012        PMID: 23661827      PMCID: PMC3645165     

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  16 in total

1.  Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.

Authors:  G B Kristensen; R Holm; V M Abeler; C G Tropé
Journal:  Cancer       Date:  1996-08-01       Impact factor: 6.860

Review 2.  Endometrial carcinoma.

Authors:  P G Rose
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

Review 3.  Epidemiology of endometrial cancer.

Authors:  L F Voigt; N S Weiss
Journal:  Cancer Treat Res       Date:  1989

Review 4.  Cancer of the uterine cervix.

Authors:  S A Cannistra; J M Niloff
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

5.  Invasive cervical cancer rising in young white females.

Authors:  N S Larsen
Journal:  J Natl Cancer Inst       Date:  1994-01-05       Impact factor: 13.506

6.  p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.

Authors:  T D Kessis; R J Slebos; S M Han; K Shah; X F Bosch; N Muñoz; L Hedrick; K R Cho
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.

Authors:  B L Harlow; N S Weiss; G J Roth; J Chu; J R Daling
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

Review 8.  Oncogenesis of squamous carcinoma of the uterine cervix.

Authors:  B S Nair; R Pillai
Journal:  Int J Gynecol Pathol       Date:  1992       Impact factor: 2.762

9.  Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia.

Authors:  C La Vecchia; S Franceschi; A Decarli; M Fasoli; A Gentile; F Parazzini; M Regallo
Journal:  Cancer       Date:  1986-08-15       Impact factor: 6.860

10.  Hereditary ovarian cancer. Heterogeneity in age at diagnosis.

Authors:  H T Lynch; P Watson; C Bewtra; T A Conway; C R Hippee; P Kaur; J F Lynch; B A Ponder
Journal:  Cancer       Date:  1991-03-01       Impact factor: 6.860

View more
  5 in total

1.  Vulvar cancer in Botswana in women with and without HIV infection: patterns of treatment and survival outcomes.

Authors:  Emily MacDuffie; Sruthi Sakamuri; Rebecca Luckett; Qiao Wang; Memory Bvochara-Nsingo; Barati Monare; Lisa Bazzett-Matabele; Thabo Moloi; Tlotlo Ralefala; Doreen Ramogola-Masire; Sanghyuk S Shin; Nicola M Zetola; Surbhi Grover
Journal:  Int J Gynecol Cancer       Date:  2021-09-07       Impact factor: 3.437

2.  The pattern of gynecological malignancies in Al-Madinah Al-Munawarah region, Saudi Arabia: An overview of 6 years.

Authors:  Nawal H Almohammadi
Journal:  Saudi Med J       Date:  2022-03       Impact factor: 1.422

3.  Cancer of the vulva in Burkina Faso: a hospital-based case series.

Authors:  Nayi Zongo; Nina Korsaga-Somé; Amandine Banata Gang-Ny; Edgar Ouangré; Maurice Zida; Aimé Sosthène Ouédraogo; Aboubacar Hirrhum Bambara; Augustin Tozoula Bambara; Si Simon Traore; Pascal Niamba; Adama Traoré; Ahmadou Dem
Journal:  Infect Agent Cancer       Date:  2016-08-03       Impact factor: 2.965

4.  Vulva cancer in Ghana - Review of a hospital based data.

Authors:  Mary Ann Dadzie; Charles A Aidoo; Verna Vanderpuye
Journal:  Gynecol Oncol Rep       Date:  2017-03-27

5.  Oncogenic viruses associated with vulva cancer in HIV-1 patients in Botswana.

Authors:  Kenneth O Simbiri; Hem C Jha; Mukendi K Kayembe; Carrie Kovarik; Erle S Robertson
Journal:  Infect Agent Cancer       Date:  2014-08-24       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.